Immunotherapy for advanced lung cancer combined with surgery for mediastinal myxofibrosarcoma: a case report

BACKGROUND: It is unclear whether simultaneous primary neoplasm resection and immunotherapy for advanced lung cancer is safe. We report a case of an elderly man with advanced lung cancer and myxofibrosarcoma. CASE PRESENTATION: The advanced lung cancer was treated with pembrolizumab, and partial res...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Tetsuya, Wakatsuki, Yusuke, Matsukura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391501/
https://www.ncbi.nlm.nih.gov/pubmed/30806844
http://dx.doi.org/10.1186/s40792-019-0596-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391501/
https://www.ncbi.nlm.nih.gov/pubmed/30806844
http://dx.doi.org/10.1186/s40792-019-0596-7

Ejemplares similares